EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology and genomics of azithromycin-resistant extensively drug-resistant Salmonella enterica serovar Typhimurium in Taiwan

Yu-Ping Hong iD, Ying-Shu Liao, Bo-Han Chen, You-Wun Wang iD, Ru-Hsiou Teng, Shiu-Yun Liang, Hsiao Lun Wei, Jui-Hsien Chang, Chien-Shun Chiou iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01334-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Yu-Ping Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan. Hauptthemen laut MEDLINE: Azithromycin, Salmonella typhimurium, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent emergence of azithromycin-resistant extensively drug-resistant (AziR-XDR) Salmonella enterica serovar Typhimurium ( S . Typhimurium) in Taiwan poses a significant public health concern. To investigate the genetic basis and the evolutionary dynamics, we analyzed 60 isolates collected between 2007 and 2024, comprising multidrug-resistant (MDR, n = 45) and AziR-XDR ( n = 15) isolates from human and animal sources. Whole-genome sequencing analysis revealed that 36 of 45 MDR isolates and all AziR-XDR isolates belonged to the HC50_13 subclone (differing by ≤ 50 core genes) and clustered within the HC20_152604 cluster (differing by ≤ 20 core genes) and the SNP cluster PDS000042202. All HC50_13 MDR isolates and AziR-XDR isolates carried core resistance genes including aac(3)-IId , aph(3’’)-Ib , aph(6)-Id , blaTEM-1 , floR , sul2 , tet(A ) on type 2 IncC plasmids, and AziR-XDR isolates carried additional antimicrobial resistance genes (ARGs) on the plasmids, including blaDHA-1 , dfrA17 , mph(A ), qnrB , and sul1 , conferring additional resistance to azithromycin, trimethoprim, third-generation cephalosporins, and fluoroquinolones. AziR-XDR S. Typhimurium strains belonging to the HC50_13 subclone were initially identified in 2016 and have notably increased in Taiwan since 2021. The subclone was likely evolved from MDR ancestor strains by multiple IS 26 -mediated acquisitions of additional resistance cassettes. Our findings demonstrate how MDR S . Typhimurium can evolve locally into highly resistant strains. This underscores the need for genomic surveillance and coordinated antimicrobial stewardship in Taiwan and globally to prevent further dissemination of the highly resistant HC20_152604 clade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinSalmonella typhimuriumDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsTaiwanHumansMicrobial Sensitivity TestsAnimalsPlasmidsWhole Genome SequencingGenomicsSalmonella Infections

Stichwörter der Autor:innen

IncC plasmidantimicrobial resistanceazithromycinextensively drug-resistant (XDR)molecular epidemiologymultidrug-resistant (MDR)non-typhoidal Salmonella (NTS)resistance mechanism

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.

ORCID-Profile: Yu-Ping Hong, You-Wun Wang, Chien-Shun Chiou

Förderung

  • Ministry of Health and Welfare

Zitieren

APA

Hong, Y. P., Liao, Y. S., Chen, B. H., Wang, Y. W., Teng, R. H., Liang, S. Y., Wei, H. L., Chang, J. H., & Chiou, C. S. (2026). Epidemiology and genomics of azithromycin-resistant extensively drug-resistant Salmonella enterica serovar Typhimurium in Taiwan. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01334-25

Vancouver

Hong YP, Liao YS, Chen BH, Wang YW, Teng RH, Liang SY, et al. Epidemiology and genomics of azithromycin-resistant extensively drug-resistant Salmonella enterica serovar Typhimurium in Taiwan. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01334-25

BibTeX
@article{Hong2026,
  author = {Hong, Yu-Ping and Liao, Ying-Shu and Chen, Bo-Han and Wang, You-Wun and Teng, Ru-Hsiou and Liang, Shiu-Yun and Wei, Hsiao Lun and Chang, Jui-Hsien and Chiou, Chien-Shun},
  title = {Epidemiology and genomics of azithromycin-resistant extensively drug-resistant Salmonella enterica serovar Typhimurium in Taiwan},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01334-25}
}
Kostenlos starten →